The programme of the ESMO Symposium on Signalling Pathways in Cancer 2018 is online
The 6th edition of the ESMO Symposium on Signalling Pathways in Cancer, in partnership with the European Association for Cancer Research (EACR), focused on Cyclin-dependent kinases (CDKs).
The Symposium programme was accredited with 11 Cat. 1 ESMO-MORA points. Recertification is necessary for medical oncologists to remain professionally certified by ESMO. Recertification also guarantees that a certified medical oncologist has continued to update her/his knowledge and continue to possess the necessary skills and standards for the practice of medical oncology. See here for further details.
The ESMO Symposium on Signalling pathways in cancer 2018 was accredited by the European Accreditation Council for Continuing Medical Education (EACCME®) with 10 European CME credits (ECMEC®s). Each medical specialist should claim only those hours of credit that he/she actually spent in the educational activity.
Through an agreement between the Union Européenne des Médecins Spécialistes and the American Medical Association, physicians may convert EACCME® credits to an equivalent number of AMA PRA Category 1 CreditsTM. Information on the process to convert EACCME® credit to AMA credit can be found at www.ama-assn.org/education/earn-credit-participation-international-activities
Live educational activities, occurring outside of Canada, recognised by the UEMS-EACCME® are deemed to be Accredited Group Learning Activities (Section 1) as defined by the Maintenance of Certification Program of the Royal College of Physicians and Surgeons of Canada.
The EACCME® awards ECMEC®s on the basis of 1 ECMEC® for one hour of CME with a maximum of 8 ECMEC®s per day.